MARATTO

article · Asian Journal of Research in Infectious Diseases

SARS-CoV-2 Infection and Factors Associated with Mortality in Hospitalized Patients Aged 60 and Over at the Epidemic Treatment Center (ETC) of Saint-Louis (Senegal)

Abstract

Background: SARS-CoV-2 infection typically causes severe pneumonia in elderly patients with high mortality rates.
 Aim: This study aimed to describe the epidemiological, clinical, paraclinical and evolution profile of the SARS-CoV-2 infection in patients aged 60 years and over hospitalized at the Epidemic Treatment Center (ETC) of Saint-Louis “Senegal”, and to identify the factors associated with death.
 Methodology: This is a cross-sectional, retrospective, descriptive and analytical study conducted from March 2020 to August 2021. It includes all patients aged 60 years and older hospitalized at the ETC of Saint-Louis (Senegal) for SARS-CoV-2 infection. Microsoft Excel was used to enter data and then analysis was done using EPI INFO version 7 software.
 Results: Of a total of 448 hospitalizations, 188 patient records aged 60 years and older was collected. The prevalence was 42%. The mean age was 70 years (±8 years). The sex ratio was 1.7 with a male predominance (62.8%). Hypertension was the most common co-morbidity (67%). Severe forms were predominant (64.4%). Dyspnea (60.3%), cough (56.5%) and ageusia (24.5%) were the most common symptoms on admission. Thoracic CT scans showed severe involvement in 51.7% of cases. Hydroxychloroquine-azithromycin combination was prescribed in 98.4% of cases. The mortality rate was 18.6%. The main factors associated with death were age (≤75 years) (p=0.014) [OR=0.488; 95% CI: 0.201-1.187]; critical forms (p=0.017) [OR=0.061; 95% CI: 0.006-0.601]; comorbidity (p=0. 031) [OR=1.647; 95% CI: 0.280-2.499]; occurrence of complications (p=0.009) [OR=1.212; 95% CI: 0.530-2.774]; and SpO2≤95% at admission (p=0.031) [OR=4.899; 95% CI: 0.752-8.797].
 Conclusion: SARS-CoV-2 infection in the elderly is predominantly severe with high mortality. This high-risk group requires special attention.

Research topics

  • COVID-19 and healthcare impacts
  • Healthcare Systems and Practices
  • COVID-19 epidemiological studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.9734/ajrid/2024/v15i2327

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.